Clinical Trials
748 trialsA Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
DOTA-STR-17126
Integrated Haematology and Oncology Network
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Alterome Therapeutics, Inc.
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
GlaxoSmithKline
PIKALO-1
Eli Lilly and Company
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Immunome, Inc.
Real-Time IGRT
University of Sydney
Cancer
Federal University of Maranhao
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
AstraZeneca
FOCUS
Ohio State University Comprehensive Cancer Center
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
New Phase Ltd.
ULTIMO
Cancer Research Antwerp
Adaptive Symptom Self-Management Immunotherapy Study
University of Arizona
OP-NEU-101
Onchilles Pharma Inc
Dance Intervention in Breast Cancer Treatment
Federal University of Maranhao
LONGEVITI
University of Alberta
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Cancer Research UK
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Vanderbilt-Ingram Cancer Center
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
Case Comprehensive Cancer Center
I-SPY
QuantumLeap Healthcare Collaborative
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
Unity Health Toronto
AxeCan
HealthPartners Institute
Study of LP-184 in Patients With Advanced Solid Tumors
Lantern Pharma Inc.
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Harvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
University of Colorado, Denver
BASECAMP-1
A2 Biotherapeutics Inc.
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
CHEMOVES
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NAVIGATE
Bayer
IMPACT-
Istituto di Studi Superiori Musicali (ISSM) Conservatorio Antonio Vivaldi di Alessandria
CER
Cancer Support Community, Research and Training Institute, Philadelphia
HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases
City of Hope Medical Center
ADIE-BC
King's College London
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
SERENA-6
AstraZeneca
AI-ChemoApp
University of Baghdad
PERTUREAL
Société Algérienne de Formation et Recherche en Oncologie
LIBRETTO-001
Eli Lilly and Company
ROSY-O
AstraZeneca
AH-HA
Wake Forest University Health Sciences
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
ReRT
The New York Proton Center
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
BRIA-ABC
BriaCell Therapeutics Corporation